Advancements in antibody-drug conjugates are creating new opportunities in the HER2 Antibodies Market. These treatments combine targeted antibodies with cancer-fighting drugs to improve the delivery of therapeutic agents to cancer cells. Market Overview The HER2 Antibodies Market is expected to register a CAGR of 5.1% from 2025 to 2031. The market valuation is reported as US$ XX...